Document is current
Any future updates will be listed below
-
Authors
Tomiyama, Takahiro
Takeishi, Kazuki
Itoh, Shinji
Toshida, Katsuya
Iseda, Norifumi
Nakayama, Yuki
Ishikawa, Takuma
Motomura, Takashi
Kurihara, Takeshi
Toshima, Takeo
Florentino, Rodrigo M.
Soto-Gutierrez, Alejandro
Yoshizumi, Tomoharu
-
Funding
Funding for this research was provided by:
TERUMO LIFE SCIENCE FOUNDATION
Japan Society for the Promotion of Science (21H03004)
- License Information
-
More Information
Article History
Received: 19 November 2024
Accepted: 13 April 2025
First Online: 17 May 2025
Declarations
:
: Takeishi K, Soto-Gutierrez A. are co-founders and have a financial interest in Von Baer Wolff, Inc. and A. Soto-Guierrez is a co-founder and has a financial interest in Pittsburgh ReLiver INC. companies focused on biofabrication of autologous human hepatocytes from stem cell technology and programming liver failure, and their interests are managed by the Conflict-of-Interest Office at the University of Pittsburgh in accordance with their policies. T. Tomiyama, S. Itoh, K. Toshida, N. Iseda, Y. Nakayama, T. Motomura, T. Kurihara, T. Toshima, R. M. Florentino, and T. Yoshizumi have no conflict of interest.
: Approval of the research protocol by an Institutional Reviewer Board: N/A.
: Not applicable.
: Not applicable.
: Not applicable.
